Chinese Stem Cell Leader Beike Biotech Pioneers Customized Medicine Innovations

Stem Cell Advances for Enhanced Personalized Medicine: A Look into China's Leading Stem Cell Repository

One of China's foremost stem cell banking companies is pioneering a path towards customized medical treatments. Beike Biotech, established in Shenzhen since 2005, has carved out an esteemed position within the global stem cell industry by assembling an elite team of specialists and ambitiously ming to store over 1.7 million tubes of stem cells.

of stem cell collection and cryopreservation forms the backbone of this industry. Under Beike Biotech's leadership, we're witnessing a remarkable advancement with its specialized freezing medium - a substance that mntns efficacy at room temperature without requiring pre-cooling before storing cells. This innovation significantly streamlines operations and boosts efficiency in handling and transporting samples.

Beike Biotech boasts an intricate quality management system with over 60 patents across the entire process, from sample collection in hospitals through transportation and manufacturing up until they are frozen in liquid nitrogen tanks. Cheguo C, Chief Scientist of Beike Biotech, underlines that their comprehensive protocols reflect a deep understanding of stem cells.

C highlights an impressive development at his company: the creation of patient-derived organoids PDOs utilizing breast organoids derived from in vitro cultures using stem cell technology. These 3D tissueclosely mimic biological features of tumors and have potential implications for personalized medicine decision-making.

The PDOs are developed through a streamlined process that enables them to be cultured from either breast cancer stem cells or tissues extracted directly from patients within just ten days, mirroring the characteristics of primary tumors. This innovation allows healthcare professionals to better predict patient responses and optimize drug screening.

Beike Biotech's commitment to advancing health exts beyond its development in PDOs. The company is actively exploring further partnerships and recruitment efforts to harness their extensive knowledge base and skills in stem cell discoveries for more impactful innovations.

The Beike Biotech building, located amidst the bustling city of Shenzhen, China, stands as a testament to its dedication towards transforming medical science through innovative research capabilities.

Visit www.beike.cc for more information about this trlblazing company's mission and progress.

This advertisement is featured in Nature Spotlight 2022 Precision Medicine, an editorially indepent supplement prepared by Nature Research Custom Services. Advertisers do not influence the content of our articles.

Nature Research Custom Services

nature.comsitemap

About Nature Portfolio

Contact Us

Discover Content

Journals A-Z

Articles by Subject

protocols.io

Nature Index

Publishing Policies

Nature Portfolio Policies

Open Access

Author Researcher Services

Reprints Permissions

Research Data

Language Editing

Scientific Editing

Nature Masterclasses

Research Solutions

Libraries Institutions

Librarian Service Tools

Librarian Portal

Open Research

Recomm to Library

Advertising Partnerships

Advertising

Partnerships Services

Media Kits

Branded Content

Professional Development

Nature Careers

Nature

Conferences

Regional Websites

Nature Africa

Nature China

Nature India

Nature Italy

Nature Japan

Nature Middle East

Privacy Policy

Use of Cookies

Your Privacy ChoicesManage Cookies

Legal Notice

Accessibility Statement

Terms Conditions

Your US State Privacy Rights

2024 Springer Nature Limited
This article is reproduced from: https://www.nature.com/articles/d42473-022-00201-2

Please indicate when reprinting from: https://www.051m.com/College_of_Biotechnology_Engineering/China_Leading_Stem_Cell_Repository.html